| Literature DB >> 24384995 |
Hesham M Al-Mekhlafi1, Ebtesam M Al-Zabedi2, Mohamed T Al-Maktari3, Wahib M Atroosh4, Ahmed K Al-Delaimy5, Norhayati Moktar6, Atiya A Sallam7, Wan Ariffin Abdullah8, Rohana Jani9, Johari Surin10.
Abstract
Iron deficiency anaemia (IDA) is the most common nutritional deficiency in the world including developed and developing countries. Despite intensive efforts to improve the quality of life of rural and aboriginal communities in Malaysia, anaemia and IDA are still major public health problems in these communities particularly among children. A randomized, double-blind, placebo-controlled trial was conducted on 250 Orang Asli (aboriginal) schoolchildren in Malaysia to investigate the effects of a single high-dose of vitamin A supplementation (200,000 IU) on iron status indices, anaemia and IDA status. The effect of the supplement was assessed after 3 months of receiving the supplements; after a complete 3-day deworming course of 400 mg/day of albendazole tablets. The prevalence of anaemia was found to be high: 48.5% (95% CI=42.3, 54.8). Moreover, 34% (95% CI=28.3, 40.2) of the children had IDA, which accounted for 70.1% of the anaemic cases. The findings showed that the reduction in serum ferritin level and the increments in haemoglobin, serum iron and transferrin saturation were found to be significant among children allocated to the vitamin A group compared to those allocated to the placebo group (p<0.01). Moreover, a significant reduction in the prevalence of IDA by almost 22% than prevalence at baseline was reported among children in the vitamin A group compared with only 2.3% reduction among children in the placebo group. In conclusion, vitamin A supplementation showed a significant impact on iron status indices and IDA among Orang Asli children. Hence, providing vitamin A supplementation and imparting the knowledge related to nutritious food should be considered in the efforts to improve the nutritional and health status of these children as a part of efforts to improve the quality of life in rural and aboriginal communities.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24384995 PMCID: PMC3916855 DOI: 10.3390/nu6010190
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1A geographic map showing the study area (location of school and villages in Lipis district).
Figure 2Flow chart of data collection and follow up.
Baseline characteristics of the intervention groups *. TIBC, total iron binding capacity; IDA, iron deficiency anaemia.
| Characteristics | Vitamin A | Placebo |
|---|---|---|
| 125 | 125 | |
| Male/Female | 63/62 | 63/62 |
| Age (years) a | 10 (8, 11) | 10 (9, 11) |
| Haemoglobin (g/dL) a | 12.1 (10.3, 12.2) | 12.0 (10.2, 12.2) |
| Serum ferritin (μg/L) b | 15.5 ± 6.8 | 15.7 ± 6.7 |
| Serum iron (μmol/L) a | 10.8(9.9, 15.3) | 11.2(9.7, 15.7) |
| TIBC (μmol/L) b | 72.8 ± 8.5 | 72.4 ± 10.7 |
| Transferrin Saturation b | 17.7 ± 6.9 | 18.3 ± 8.0 |
| Anaemia c | 59 (48.8) | 58 (48.3) |
| IDA c | 43 (35.5) | 39 (32.5) |
| Serum retinol (μmol/L) a | 1.12 (0.69, 1.47) | 1.14 (0.69, 1.40) |
| Ascariasis (%) | 87 (69.6) | 82 (65.6) |
| Trichuriasis (%) | 120 (96.0) | 122 (97.6) |
| Hookworm infections (%) | 18 (14.4) | 13 (10.4) |
| Giardiasis (%) | 18 (14.4) | 27 (21.6) |
* All differences were non-significant; N: Represents the number of subjects; a Median (IQR), p-values for the differences between vitamin A and placebo groups (Mann-Whitney U test); b Mean ± SD, p-values for the differences between vitamin A and placebo groups (independent t-test); c Number (%) p-values for the differences between vitamin A and placebo groups (Chi-square test).
Correlation between serum retinol and iron status indices at baseline according to age and gender. SR, serum retinol; Hb, haemoglobin; SF, serum ferritin; TS, transferrin saturation.
| Gender/Age Groups | SR + Hb | SR + SF | SR + TS | |
|---|---|---|---|---|
| 241 | 0.276 * | 0.195 * | 0.331 ** | |
| ≤10 years | 167 | 0.224 * | 0.170 | 0.266 * |
| >10 years | 74 | 0.202 | 0.166 | 0.473 ** |
| Males | 120 | 0.186 | 0.111 | 0.284 ** |
| Females | 121 | 0.252 * | 0.282 ** | 0.305 ** |
* Correlation was significant at the 0.05 level; ** Correlation was significant at the 0.01 level.
Mean changes in Hb and iron status indices from baseline 3 months after intervention in the vitamin A and placebo groups a.
| Variable | Vitamin A | Placebo |
|---|---|---|
| Haemoglobin (g/dL) | 0.51 (0.40, 0.56) b,1 | 0.21 (0.15, 0.28) |
| Serum ferritin (μg/L) | −1.50 (−2.68, −0.33) b,2 | 0.90 (0.20, 1.61) |
| Serum iron (μmol/L) | 1.60 (1.16, 2.0) b,2 | 0.49 (0.02, 0.98) |
| TIBC (μmol/L) | −4.30 (−6.18, −2.44) | −1.53 (−3.64, 0.58) |
| Transferrin saturation | 4.38 (3.15, 5.62) b,2 | 1.34 (0.95, 2.7) |
a All values are mean (95% CI); b Significant difference from placebo group (independent t-test): (1 p < 0.001, 2 p < 0.01).
Effects of vitamin A supplementation on prevalence of anaemia and IDA after 3 months.
| Group | Prevalence of anaemia (%) | Prevalence of IDA (%) | ||
|---|---|---|---|---|
| Baseline | After 3 months | Baseline | After 3 months | |
| Vitamin A | 59 (47.2) | 34 (27.2) | 43 (34.4) | 15 (12.0) |
| Placebo | 58 (46.4) | 40 (32.0) | 39 (31.2) | 32 (25.6) |
| 0.947 | 0.378 | 0.619 | 0.005 | |
Values are number of anaemic cases (%); P: p-value for the difference between the two groups (Chi-square test).
Mean changes in Hb and SF among schoolchildren in the vitamin A and placebo groups according to selected variables.
| Variables | Haemoglobin (g/dL) | Serum ferritin (μg/L) | ||
|---|---|---|---|---|
| Vitamin A | Placebo | Vitamin A | Placebo | |
| ≤10 years | 0.56 (0.4–0.7) a,b,1 | 0.18 (0.1–0.3) | −2.1 (−3.7–−0.5) b,2 | 1.7 (0.5–2.8) a |
| >10 years | 0.48 (0.3–0.6) | 0.25 (0.2–0.5) | −0.8 (−3.0–1.3) | −0.9 (−3.7–1.3) |
| Males | 0.47 (0.4–0.6) b,3 | 0.25 (0.1–0.4) | −2.9 (−4.8–−1.1) b,1 | 1.4 (−0.4–3.1) |
| Females | 0.54 (0.4–0.7) b,1 | 0.19 (0.1–0.3) | −0.59 (−2.4–1.2) | 0.77 (−0.7–2.2) |
| ≥6 years formal education | 0.39 (0.2–0.5) b,3 | 0.23 (0.1–0.3) | −4.3 (−6.9–−1.6) b,1 | 1.5 (0.4–2.7) |
| No formal education | 0.53 (0.4–0.6) b,1 | 0.15 (–0.1–0.3) | −1.2 (−2.6–0.3) | −0.7 (−4.1–2.6) |
| Low (<10 μg/L) | 0.53 (0.1–0.6) b,1 | 0.13 (0.01–0.3) | −0.1 (−2.2–2.2) | 0.9 (−1.1–2.9) |
| Normal (≥10 μg/L) | 0.50 (0.4–0.6) b,2 | 0.24 (0.2–0.3) | −2.5 (−4.1–−0.9) b,2 | 1.1 (−0.2–2.5) |
Values are mean (95% CI); a Significant difference between the variable groups: independent t-test (p < 0.05); b Significant difference between the vitamin and placebo groups: independent t-test (1 p < 0.001, 2 p < 0.01, 3 p < 0.05).
Mean changes in SI, TIBC and TS among schoolchildren in the vitamin A and placebo groups according to selected variables.
| Variable | Serum Iron (μmol/L) | TIBC (μmol/L) | Transferrin Saturation | |||
|---|---|---|---|---|---|---|
| Vitamin A | Placebo | Vitamin A | Placebo | Vitamin A | Placebo | |
| ≤10 years | 1.4 (0.9–1.9) b,1 | 0.3 (−0.4–0.9) | −5.9 (−7.2–−2.4) b,1 | −1.1 (−3.5–1.4) | 4.4 (2.8–5.9) b,2 | 1.7 (−0.4–2.5) |
| >10 years | 2.1 (1.2–3.1) b,3 | 1.1 (0.1–2.1) | −3.9 (−8.1–0.2) | −3.5 (−6.1–4.2) | 5.4 (2.5–8.3) b,3 | 2.7 (−1.4–4.6) |
| Males | 1.8 (1.1–2.4) b,2 | 0.5 (−0.3– 0.9) | −5.0 (−7.9–−2.1) b,1 | 1.1 (−1.9–4.1) | 5.0 (3.0–7.1) b,1 | 0.2 (−1.7–2.0) |
| Females | 1.5 (0.9–2.1) | 0.8 (0.1–1.4) | −4.2 (−4.1–−1.2) | −4.1(−7.8–−0.4) a | 4.3 (2.5–6.1) | 2.5 (0.5–4.5) a |
| ≥6 years formal education | 1.6 (0.3–2.8) b,2 | 0.4 (−0.2–1.0) | −4.1 (−9.2–0.9) b,1 | −0.5 (–3.2–2.1) | 4.7 (0.4–8.9) b,2 | 1.5 (−0.5–2.6) |
| No formal education | 1.6 (1.1–2.1) b,3 | 0.6 (−0.9–2.0) | −4.7 (−6.9–−2.4) | −5.3 (–7.4–0.5) a | 4.7 (3.3–6.1) | 2.3 (−0.9–5.5) |
| Low (<10 μg/L) | 1.6 (1.0–2.1) | 0.8 (0.2–1.7) | −4.4 (–8.3–−0.5) b,3 | −1.9 (−6.3–2.4) | 3.9 (1.6–6.2) b,3 | 1.7 (−0.4–3.7) |
| Normal (≥10 μg/L) | 1.6 (1.1–2.2) b,2 | 0.3 (−0.4–0.7) | −4.7 (−7.1–−2.2) b,2 | −1.4 (−4.3–1.5) | 5.1 (3.3–6.7) b,2 | 1.2 (−0.6–2.9) |
Values are mean (95% CI); a Significant difference between the variable groups: independent t-test (p < 0.05); b Significant difference between the vitamin and placebo groups: independent t-test (1 p < 0.001, 2 p < 0.01, 3 p < 0.05).